He Designed Drugs to Save His Children. Now He's Working to Save Biotech, Too.

John Crowley will become a top lobbyist for the industry as it confronts investor skepticism and regulatory challenges

Related Keywords

New Jersey ,United States ,John Crowley ,Cheesecake Factory ,Kwexclusive ,Photo Commission ,Wsjhealth ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,North America ,Northeast Us ,Regulation Government Policy ,Corporate Industrial News ,Biology ,Biotechnology ,Political General News ,Sciences Humanities ,Content Types ,Factiva Filters ,C Ampe Industry News Filter ,Synd ,Wsj Pro Com ,Amicus Therapeutics ,Fold ,Michelle Mcmurry Heath ,Rachel King ,Ted Love ,Link I16 Wp Wsj 0001400926 ,Link I7 Wp Wsj 0001400926 ,Link I3 Wp Wsj 0001400926 ,Link I17 Wp Wsj 0001400926 ,Link I11 Wp Wsj 0001400926 ,Link I2 Wp Wsj 0001400926 ,Link I14 Wp Wsj 0001400926 ,Link I1 Wp Wsj 0001400926 ,Link I4 Wp Wsj 0001400926 ,Link I15 Wp Wsj 0001400926 ,Regulation ,Government Policy ,Corporate ,Industrial News ,Political ,General News ,Sciences ,Humanities ,Healthcare ,Life Sciences ,